Purchase commitments : Big business bias or solution to the 'neglected diseases' dilemma?
Lofgren, Hans 2005, Purchase commitments : Big business bias or solution to the 'neglected diseases' dilemma?, Australian review of public affairs, pp. 1-5.
Attached Files
(Some files may be inaccessible until you login with your Deakin Research Online credentials)
Name
Description
MIMEType
Size
Downloads
Title
Purchase commitments : Big business bias or solution to the 'neglected diseases' dilemma?
School of Economics and Political Science, University of Sydney
Place of publication
Sydney, N.S.W.
Publication date
2005-10-31
ISSN
1832-1526
Summary
Miniscule research resources are allocated to researching the diseases of developing countries such as malaria, tuberculosis (TB), dengue fever, river blindness, Chagas disease and leishmaniasis, and the strains of HIV prevalent in Africa. Plainly, the patent system and the commercial model of drug research fail to respond to the needs of the poor for the simple reason that the poor exercise little purchasing power. But pressures are mounting on governments and corporations to tackle the ‘neglected diseases’ calamity. An important argument in an intense global debate is that corporations would respond to the needs of developing countries if the diseases of the poor could be made profitable. This is the idea developed by Kremer and Glennerster in a crisply written book, Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases.